Alignment Healthcare(US:ALHC) Financial Modeling Prep·2025-10-31 06:03Financial Performance - Alignment Healthcare, Inc. reported an EPS of $0.02, significantly surpassing the estimated EPS of -$0.01, resulting in an earnings surprise of 128.57% [1][5] - The company's revenue for the quarter was approximately $993.7 million, exceeding the estimated revenue of about $980.9 million, representing a 1.30% increase over the Zacks Consensus Estimate and a substantial rise from $692.43 million reported in the same period last year [2][5] Strategic Discussion - During the earnings call on October 30, 2025, key executives, including the Founder and CEO John Kao and CFO James Head, discussed the company's financial performance and strategic initiatives, attended by analysts from major financial institutions [3] Valuation Metrics - ALHC has a price-to-sales ratio of about 1.02, indicating that investors are paying $1.02 for every dollar of the company's sales, reflecting a reasonable valuation [4] - The enterprise value to sales ratio is approximately 0.97, suggesting a relatively lower valuation when considering debt and cash [4] - The company has a debt-to-equity ratio of about 2.34, indicating more than twice as much debt as equity, while a current ratio of approximately 1.66 suggests good liquidity to cover short-term liabilities [4]